Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro

Human Pathology

Volumn 41, Issue 12, 2010, Pages 1742-1748

  Morikawa, Teppei ^a   Hino, Rumi ^a   Uozaki, Hiroshi ^a   Maeda, Daichi ^a   Ushiku, Tetsuo ^a   Shinozaki, Aya ^a   Sakatani, Takashi ^a   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Epstein Barr virus; Gastric cancer; Immunohistochemistry; Ribonucleotide reductase M2 subunit; Small interfering RNA

Indexed keywords

DNA METHYLTRANSFERASE 1; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE M2; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CANCER TISSUE; CONTROLLED STUDY; ENZYME SUBUNIT; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SEX DIFFERENCE; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH MUSCLE;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME INHIBITORS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTRIC MUCOSA; GENE SILENCING; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSFECTION;

EID: 78449268580     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.06.001     Document Type: Article

References (32)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. Ohtsu A., Yoshida S., and Saijo N. Disparities in gastric cancer chemotherapy between the East and West J Clin Oncol 24 2006 2188 2196
3. Thelander M., Graslund A., and Thelander L. Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2-overproducing mouse cells J Biol Chem 260 1985 2737 2741
4. Eriksson S., and Martin D.W. Jr. Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2 J Biol Chem 256 1981 9436 9440
5. Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., and Whang E.E. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine Oncogene 23 2004 1539 1548 (Pubitemid 38406516)
6. Duxbury M.S., and Whang E.E. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness Biochem Biophys Res Commun 354 2007 190 196
7. Souglakos J., Boukovinas I., and Taron M. Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine Br J Cancer 98 2008 1710 1715
8. Ito H., Funahashi S., and Yamauchi N. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target Clin Cancer Res 12 2006 3257 3264
9. Hino R., Uozaki H., and Inoue Y. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A Cancer Res 68 2008 1427 1435
10. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31 49
11. L.H. Sobin, C. Wittekind, 6th ed. TNM classification of malignant tumours 2002 Wiley & Sons New York
12. Morikawa T., Goto A., and Tomita K. Recurrent prostatic stromal sarcoma with massive high-grade prostatic intraepithelial neoplasia J Clin Pathol 60 2007 330 332
13. Hino R., Uozaki H., and Murakami N. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma Cancer Res 69 2009 2766 2774
14. Ushiku T., Chong J.M., and Uozaki H. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma Int J Cancer 120 2007 60 66
15. Fukayama M., Hayashi Y., and Iwasaki Y. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach Lab Invest 71 1994 73 81
16. Oh S.T., Seo J.S., and Moon U.Y. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer Virology 320 2004 330 336
17. Morikawa T., Sugiyama A., and Kume H. Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma Clin Cancer Res 13 2007 5703 5709
18. Liu X., Zhou B., and Xue L. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer Clin Colorectal Cancer 6 2007 374 381
19. Kolesar J., Huang W., and Eickhoff J. Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors Cancer Chemother Pharmacol 64 2009 79 86
20. Yun H.J., Cho Y.H., and Moon Y. Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2 Exp Mol Med 40 2008 345 353
21. Coutinho-Camillo C.M., Lourenco S.V., Nishimoto I.N., Kowalski L.P., and Soares F.A. Nucleophosminp53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray Hum Pathol 41 2010 1079 1086
22. Walts A.E., and Bose S. p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia Hum Pathol 40 2009 957 964
23. Gejman R., Swearingen B., and Hedley-Whyte E.T. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas Hum Pathol 39 2008 758 766
24. Rosa F.E., Caldeira J.R., and Felipes J. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers Hum Pathol 39 2008 720 730
25. Tsamandas A.C., Kardamakis D., and Tsiamalos P. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome Anticancer Res 29 2009 703 709
26. Fukayama M., Hino R., and Uozaki H. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma Cancer Sci 99 2008 1726 1733
27. Nabilsi N.H., Broaddus R.R., and Loose D.S. DNA methylation inhibits p53-mediated survivin repression Oncogene 28 2009 2046 2050
28. Kimura H., and Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1 J Biol Chem 278 2003 4806 4812
29. Chang M.S., Uozaki H., and Chong J.M. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus Clin Cancer Res 12 2006 2995 3002
30. Fan H., Villegas C., and Wright J.A. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential Proc Natl Acad Sci U S A 93 1996 14036 14040
31. Lin Z.P., Belcourt M.F., Cory J.G., and Sartorelli A.C. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors J Biol Chem 279 2004 27030 27038
32. Itoi T., Sofuni A., and Fukushima N. Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas J Gastroenterol 42 2007 389 394